Metronomic dosing of chemotherapy: applications in pediatric oncology.
about
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer.Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiationSuppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinomaAntiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.Natural products against cancer angiogenesis.Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study.Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience.Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment.Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts.Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancerA case of relapsing spinal atypical teratoid/rhabdoid tumor (AT/RT) responding to vinorelbine, cyclophosphamide, and celecoxib
P2860
Q33403308-C4986925-F288-4AA4-85B3-3779DEBCFBA5Q33858898-EF9514BB-934A-41E9-8FEC-521F30BC1537Q34158974-AAC0E72F-2DE8-4FC4-AC70-8CCBCEDE5A06Q35014219-5A694745-A80A-4962-BEEA-CD2D2145211FQ37528441-B7B6A281-1245-43B6-9DF2-9BD136B66CAEQ37752435-346D47A6-9D6F-4F32-94B5-F5D4389D323BQ38960257-B82722DD-EF03-48AC-AF4D-7CB99B223B64Q39501053-8AB943B6-A47E-4D21-8313-219CD99EBF97Q39705238-9B751655-325B-4D3C-A067-1F3A12E3E931Q40264175-4DD9621B-391F-4060-8907-65819988DB83Q40306627-B4F03F3E-187F-4095-8C03-07ED3FA102CFQ41912972-E8B0FE4A-8013-436C-8D3A-23CEEC91FF84Q57541220-00E4A418-0AAA-449E-A899-27162A7B9941Q58048193-F8EBA70B-8679-4A04-89CE-6BC9887791C8
P2860
Metronomic dosing of chemotherapy: applications in pediatric oncology.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@ast
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@en
type
label
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@ast
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@en
prefLabel
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@ast
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@en
P2093
P2860
P1433
P1476
Metronomic dosing of chemotherapy: applications in pediatric oncology.
@en
P2093
Diana Stempak
Dugald Seely
Sylvain Baruchel
P2860
P304
P356
10.1080/07357900600705599
P577
2006-06-01T00:00:00Z